Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 1,648,600 | 1,569,600 | 1,553,100 | 1,532,200 | 1,412,700 |
| Cost of Goods | 362,600 | 343,000 | 345,200 | 344,400 | 301,600 |
| Gross Profit | 1,286,000 | 1,226,600 | 1,207,900 | 1,187,800 | 1,111,100 |
| Operating Expenses | 809,000 | 1,075,500 | 901,000 | 777,000 | 716,900 |
| Operating Income | 477,600 | 151,100 | 307,100 | 411,200 | 394,800 |
| Other Income | -18,600 | -60,700 | 41,300 | -11,000 | 39,100 |
| Pre-tax Income | 459,000 | 90,400 | 348,400 | 400,200 | 433,900 |
| Income Tax | 78,300 | 26,200 | 56,100 | 64,300 | 70,300 |
| Net Income Continuous | 380,700 | 64,200 | 292,300 | 335,900 | 363,600 |
| Net Income Discontinuous | N/A | 27,000 | -2,000 | -4,400 | -7,200 |
| Minority Interests | N/A | 0 | -800 | -1,700 | -1,600 |
| Net Income | $380,700 | $91,200 | $291,100 | $333,200 | $358,000 |
| EPS Basic Total Ops | 0.66 | 0.16 | 0.50 | 0.57 | 0.61 |
| EPS Basic Continuous Ops | 0.66 | 0.11 | 0.50 | 0.58 | 0.62 |
| EPS Basic Discontinuous Ops | N/A | 0.05 | 0.00 | -0.01 | -0.01 |
| EPS Diluted Total Ops | 0.66 | 0.16 | 0.50 | 0.56 | 0.61 |
| EPS Diluted Continuous Ops | 0.66 | 0.12 | 0.50 | 0.57 | 0.62 |
| EPS Diluted Discontinuous Ops | N/A | 0.04 | 0.00 | -0.01 | -0.01 |
| EPS Diluted Before Non-Recurring Items | 0.78 | 0.58 | 0.67 | 0.67 | 0.64 |
| EBITDA(a) | $518,500 | $193,800 | $346,300 | $449,300 | $431,400 |